Patent · US Active

SARMs and method of use thereof

US9844528B2 · kind B2 · utility

4Cited by

49References

43Claims

0Family size

Assignee

University of Tennessee Research Foundation · US

Inventors

James T. Dalton · Columbus, US
Thamarai Ponnusamy · Memphis, US
Ramesh Narayanan · Cordova, US

Key dates

Filing date	Jun 23, 2016
Grant date	Dec 19, 2017
Priority date	—
Expiry date	Jun 23, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K45/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention is directed to substituted acylanilide compounds and uses thereof in treating muscular dystrophies such as Duchenne muscular dystrophy and Becker muscular dystrophy and in improving or preserving lung function and cardiac function in a subject suffering from Duchenne muscular dystrophy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.